Stocks
Iovance Biotherapeutics (IOVA) Operating Income US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Operating Income, bln rub | -206.9 | -261.9 | -342.7 | -398.9 | -460.6 | -430.0 | |||
| Changes by years, y/y, % | +61% | +27% | +31% | +16% | +15% | +29.1% | |||
Iovance Biotherapeutics. Operating Income, bln rub
Iovance Biotherapeutics. Operating Income, changes, %
Iovance Biotherapeutics. Operating Income, sum by quarters, bln rub
Iovance Biotherapeutics (IOVA) Operating Income US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Operating Income, bln rub | -118.4 | -121.3 | -117.7 | -101.9 | -89.1 | -430.0 | ||
| Changes by years, y/y, % | +18% | +13% | +6% | -7% | -25% | |||
| Changes by quarters, q/q, % | +8% | +2% | -3% | -13% | -13% | |||
